Top Banner
DISCUSSION ST ELEVATION MYOCARDIAL INFARCTION (STEMI)
33

Report Stemi

Dec 07, 2015

Download

Documents

Gladys Ailing

STEMI
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Report Stemi

DISCUSSION

ST ELEVATION MYOCARDIAL INFARCTION (STEMI)

Page 2: Report Stemi

DEFINITION

Acute coronary syndromes (ACS) is a term for situations where the blood supplied to the heart muscle is suddenly blocked.

• a group of conditions resulting from acute myocardial ischemia (insufficient blood flow to heart muscle)

• ranging from unstable angina (increasing, unpredictable chest pain) to myocardial infarction (heart attack).

Page 3: Report Stemi

INTRODUCTION

Page 4: Report Stemi

Histology

Page 5: Report Stemi
Page 6: Report Stemi

Pathophysiology

STEMI

Page 7: Report Stemi
Page 8: Report Stemi

PATHOPHYSIOLOGY

Page 9: Report Stemi

PATHOPHYSIOLOGY

Page 10: Report Stemi

PATHOPHYSIOLOGY

Page 11: Report Stemi

PATHOPHYSIOLOGY

Page 12: Report Stemi

PATHOPHYSIOLOGY

Page 13: Report Stemi
Page 14: Report Stemi

ACUTE CORONARY SYNDROME

Page 15: Report Stemi

DIAGNOSIS

Presenting symptoms

Electrocardiography

Serum markers

severe, persistent, typically chest pail; radiating to neck, jaw, or left shoulder and arm

Page 16: Report Stemi

CLINICALMANIFESTATION

Page 17: Report Stemi

Pathomechanism of Symptoms Angina Chest Pain

Acute Coron

ary Syndrome

Oxygen

supply

decrease ; Oxyg

en dema

nd increa

se

Ischemic of Heart

Metabolism aerob

to anaer

ob

Result ->

Lactate Acid increa

se

pH increase in

miocardium

Angina

Chest Pain

Page 18: Report Stemi
Page 19: Report Stemi

Electrocardiography

Page 20: Report Stemi

Electrocardiography

Page 21: Report Stemi

Because troponin and CK-MB levels do not become elevated in the serum until at least a few hours after the onset of MI symptoms and the diagnostic utility of these biomarkers is limited in that critical period. As a result, early decision making in patients with ACS often relies most heavily on the patient’s history and ECG findings.

Serum markers

Page 22: Report Stemi

DIAGNOSIS

Page 23: Report Stemi
Page 24: Report Stemi

GOAL OF TREATMENT

Relieve pain

Hemodynamic stabilization

Myocardial reperfusion

Prevent the complication

Page 25: Report Stemi

MANAGEMENT - Medications -

Page 26: Report Stemi
Page 27: Report Stemi

MANAGEMENT - Reperfusion Therapy -

Page 28: Report Stemi

MANAGEMENT - Reperfusion Therapy -

Page 29: Report Stemi

MANAGEMENT - Reperfusion Therapy -

Absolute contraindications• Any prior ICH• Known structural cerebral vascular lesion (e.g. arteriovenous

malformation)• Known malignant intracranial neoplasm (primary or metastatic)

Ischaemic stroke within 3 mo EXCEPT acute ischaemic stroke within 4.5 h

• Suspected aortic dissection• Active bleeding or bleeding diathesis (excluding menses)• Significant closed-head or facial trauma within 3 mo• Intracranial or intraspinal surgery within 2 mo• Severe uncontrolled hypertension (unresponsive to emergency

therapy)• For streptokinase, prior treatment within the previous 6 mo

Page 30: Report Stemi

MANAGEMENT - Reperfusion Therapy -

Relative contraindications• History of chronic, severe, poorly controlled hypertension• Significant hypertension on presentation (SBP >180 mmHg or DBP

>110 mmHg)• History of prior ischaemic stroke >3 mo• Dementia• Known intracranial pathology not covered in absolute

contraindications• Traumatic or prolonged (>10 min) CPR• Major surgery (<3 wk)• Recent (within 2 to 4 wk) internal bleeding• Non-compressible vascular punctures• Pregnancy• Active peptic ulcer• Oral anticoagulant therapy

Page 31: Report Stemi

COMPLICATIONS

Page 32: Report Stemi

PROGNOSIS

Page 33: Report Stemi